Bone mineral density abnormalities in patients with HIV infection - PubMed (original) (raw)

Bone mineral density abnormalities in patients with HIV infection

Julian Gold et al. J Acquir Immune Defic Syndr. 2002.

No abstract available

PubMed Disclaimer

Similar articles

• Anti-HIV agents. Efavirenz versus indinavir: who really wins?
  [No authors listed] [No authors listed] TreatmentUpdate. 2000 Feb;12(1):4-5. TreatmentUpdate. 2000. PMID: 12125628 Clinical Trial. No abstract available.
• Efavirenz in HIV infection.
  Casado JL, Moreno S. Casado JL, et al. N Engl J Med. 2000 Apr 27;342(17):1290-1. doi: 10.1056/NEJM200004273421713. N Engl J Med. 2000. PMID: 10787332 No abstract available.
• DMP 266 and indinavir combination.
  [No authors listed] [No authors listed] AIDS Patient Care STDS. 1997 Aug;11(4):287-8. AIDS Patient Care STDS. 1997. PMID: 11361845 No abstract available.
• Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
  Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, Stryker R, Johnson P, Labriola DF, Farina D, Manion DJ, Ruiz NM. Staszewski S, et al. N Engl J Med. 1999 Dec 16;341(25):1865-73. doi: 10.1056/NEJM199912163412501. N Engl J Med. 1999. PMID: 10601505 Clinical Trial.
• Protease inhibitors: a new weapon and a new strategy against HIV.
  Phillips KD. Phillips KD. J Assoc Nurses AIDS Care. 1996 Sep-Oct;7(5):57-71. doi: 10.1016/S1055-3290(96)80049-5. J Assoc Nurses AIDS Care. 1996. PMID: 8906736 Review.

Cited by

• DUAL-ENERGY X-RAY ABSORPTIOMETRY AND CALCULATED FRAX RISK SCORES MAY UNDERESTIMATE OSTEOPOROTIC FRACTURE RISK IN VITAMIN D-DEFICIENT VETERANS WITH HIV INFECTION.
  Stephens KI, Rubinsztain L, Payan J, Rentsch C, Rimland D, Tangpricha V. Stephens KI, et al. Endocr Pract. 2016 Apr;22(4):440-6. doi: 10.4158/EP15958.OR. Epub 2015 Dec 18. Endocr Pract. 2016. PMID: 26684149 Free PMC article.
• Adenovirus 36, adiposity, and bone strength in late-adolescent females.
  Laing EM, Tripp RA, Pollock NK, Baile CA, Della-Fera MA, Rayalam S, Tompkins SM, Keys DA, Lewis RD. Laing EM, et al. J Bone Miner Res. 2013 Mar;28(3):489-96. doi: 10.1002/jbmr.1776. J Bone Miner Res. 2013. PMID: 23296755 Free PMC article.
• Low bone-mineral density in patients with HIV: pathogenesis and clinical significance.
  Yin MT, Shane E. Yin MT, et al. Curr Opin Endocrinol Diabetes. 2006 Dec 1;13(6):497-502. doi: 10.1097/MED.0b013e3280109b6c. Curr Opin Endocrinol Diabetes. 2006. PMID: 20467568 Free PMC article.
• Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.
  Triant VA, Brown TT, Lee H, Grinspoon SK. Triant VA, et al. J Clin Endocrinol Metab. 2008 Sep;93(9):3499-504. doi: 10.1210/jc.2008-0828. Epub 2008 Jul 1. J Clin Endocrinol Metab. 2008. PMID: 18593764 Free PMC article.
• Osteopenia and osteoporosis in patients with HIV: a review of current concepts.
  Brown TT, McComsey GA. Brown TT, et al. Curr Infect Dis Rep. 2006 Mar;8(2):162-70. doi: 10.1007/s11908-006-0012-x. Curr Infect Dis Rep. 2006. PMID: 16524553

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Medical

  • MedlinePlus Health Information